Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Omada Health, Inc.OMDA · Entity 2364 | Director · Chief Executive Officer | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Omada Health, Inc.
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 382,594 |
Ending reported balance
After 2026-10-01 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-10-01 · Exercise / conversion · Acquired 12,944 · Balance 395,538 F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. Row 2 · 2026-10-01 · Exercise / conversion · Acquired 4,314 · Balance 399,852 F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. Row 3 · 2026-10-01 · Sale · Disposed 12,944 · Balance 386,908 F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. F2: This transaction was executed in multiple trades at prices ranging from $20.11 to $20.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 4 · 2026-10-01 · Sale · Disposed 4,314 · Balance 382,594 F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.82 · Expires 2029-08-21 | Direct | 116,595 |
Reported balance
After 2026-10-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-10-01 · Exercise / conversion · Disposed 12,944 · Balance 116,595 F4: 100% of the shares subject to the option are fully vested and exercisable. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.28 · Expires 2031-05-05 | Direct | 101,904 |
Reported balance
After 2026-10-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-10-01 · Exercise / conversion · Disposed 4,314 · Balance 101,904 F4: 100% of the shares subject to the option are fully vested and exercisable. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 851,659 |
Reported balance
Holding disclosure · report date 2026-10-01 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 851,659 F3: Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
F2: This transaction was executed in multiple trades at prices ranging from $20.11 to $20.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
F4: 100% of the shares subject to the option are fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 24, 2026 Filed Jun 26, 2026 23:35 UTC | Omada Health, Inc. OMDA · Entity 2364 | SaleCommon Stock | 2,800 | $19.01 | $53,238.92 |
DisclosureSEC source: 0001610717-26-000299 · form4.xml · nonDerivative · entry 1 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 409,061 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 24, 2026 Filed Jul 9, 2026 00:22 UTC Amendment | Omada Health, Inc. OMDA · Entity 2364 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,800 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0001610717-26-000335 · form4a.xml · derivative · entry 10 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 178,515 Underlying: Common Stock · 2,800 shares Expires 2029-08-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. F6 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable Read SEC document |
| June 24, 2026 Filed Jul 9, 2026 00:22 UTC Amendment | Omada Health, Inc. OMDA · Entity 2364 | SaleCommon Stock | 2,800 | $19.01 | $53,238.92 |
DisclosureSEC source: 0001610717-26-000335 · form4a.xml · nonDerivative · entry 2 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 411,861 F2 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. F3 · price: This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F1 · balance_after: This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. Read SEC document |
| June 24, 2026 Filed Jul 9, 2026 00:22 UTC Amendment | Omada Health, Inc. OMDA · Entity 2364 | Exercise / conversionCommon Stock | 2,800 | $5.82 | $16,296.00 |
DisclosureSEC source: 0001610717-26-000335 · form4a.xml · nonDerivative · entry 1 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 414,661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:18 UTC | Omada Health, Inc. OMDA · Entity 2364 | SaleCommon Stock | 14,960 | $17.36 | $259,711.58 |
DisclosureSEC source: 0001610717-26-000248 · form4.xml · nonDerivative · entry 1 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 411,861 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 20:43 UTC | Omada Health, Inc. OMDA · Entity 2364 | GiftCommon Stock | 9,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-26-000199 · form4.xml · nonDerivative · entry 2 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 426,821 Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 20:43 UTC | Omada Health, Inc. OMDA · Entity 2364 | Tax withholdingCommon Stock | 4,422 | $17.93 | $79,286.46 |
DisclosureSEC source: 0001610717-26-000199 · form4.xml · nonDerivative · entry 1 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 436,271 Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:17 UTC | Omada Health, Inc. OMDA · Entity 2364 | Tax withholdingCommon Stock | 9,884 | $18.38 | $181,667.92 |
DisclosureSEC source: 0001610717-26-000180 · form4.xml · nonDerivative · entry 1 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 440,693 F1 · balance_after: Includes 9,450 shares previously held in family trusts that were transferred to the Reporting Person on December 29, 2025 and are now owned directly. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:11 UTC | Omada Health, Inc. OMDA · Entity 2364 | SaleCommon Stock | 200 | $14.89 | $2,977.00 |
DisclosureSEC source: 0001610717-26-000091 · form4.xml · nonDerivative · entry 2 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,598 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 15, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $14.86 to $14.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:11 UTC | Omada Health, Inc. OMDA · Entity 2364 | SaleCommon Stock | 3,863 | $14.32 | $55,299.23 |
DisclosureSEC source: 0001610717-26-000091 · form4.xml · nonDerivative · entry 1 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,798 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 15, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $13.81 to $14.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 23:07 UTC | Omada Health, Inc. OMDA · Entity 2364 | Tax withholdingCommon Stock | 4,983 | $13.60 | $67,768.80 |
DisclosureSEC source: 0001610717-26-000088 · form4.xml · nonDerivative · entry 1 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,661 Read SEC document |
| March 05, 2026 Filed Mar 13, 2026 22:59 UTC | Omada Health, Inc. OMDA · Entity 2364 | GrantCommon Stock | 323,529 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-26-000096 · form4.xml · nonDerivative · entry 1 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 441,127 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/16th of the RSUs vest on each quarterly anniversary measured from March 1, 2026 (the "Vesting Commencement Date"), such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date. F2 · balance_after: The number of shares beneficially owned reported in Column 5 is as of the date of this filing and takes into account transactions reported on a Form 4 filed on 3/11/2026. Read SEC document |
| January 13, 2026 Filed Jan 14, 2026 23:01 UTC | Omada Health, Inc. OMDA · Entity 2364 | Exercise / conversionStock Option (Right to Buy) · Derivative | 40,796 | $0.00 Strike: $2.55 | $0.00 |
DisclosureSEC source: 0001610717-26-000015 · form4.xml · derivative · entry 8 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,796 shares Expires 2026-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 13, 2026 Filed Jan 14, 2026 23:01 UTC | Omada Health, Inc. OMDA · Entity 2364 | SaleCommon Stock | 40,796 | $15.95 | $650,773.71 |
DisclosureSEC source: 0001610717-26-000015 · form4.xml · nonDerivative · entry 5 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,644 F1 · shares: Represents shares underlying non-qualified stock options set to expire imminently on January 27, 2026. F4 · price: This transaction was executed in multiple trades at prices ranging from $15.61 to $16.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 13, 2026 Filed Jan 14, 2026 23:01 UTC | Omada Health, Inc. OMDA · Entity 2364 | Exercise / conversionCommon Stock | 40,796 | $2.55 | $104,029.80 |
DisclosureSEC source: 0001610717-26-000015 · form4.xml · nonDerivative · entry 4 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 23:01 UTC | Omada Health, Inc. OMDA · Entity 2364 | Exercise / conversionStock Option (Right to Buy) · Derivative | 230,479 | $0.00 Strike: $2.55 | $0.00 |
DisclosureSEC source: 0001610717-26-000015 · form4.xml · derivative · entry 7 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,796 Underlying: Common Stock · 230,479 shares Expires 2026-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 23:01 UTC | Omada Health, Inc. OMDA · Entity 2364 | SaleCommon Stock | 90,490 | $15.99 | $1,446,726.97 |
DisclosureSEC source: 0001610717-26-000015 · form4.xml · nonDerivative · entry 3 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,644 F1 · shares: Represents shares underlying non-qualified stock options set to expire imminently on January 27, 2026. F3 · price: This transaction was executed in multiple trades at prices ranging from $15.85 to $16.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 23:01 UTC | Omada Health, Inc. OMDA · Entity 2364 | SaleCommon Stock | 139,989 | $15.35 | $2,148,425.18 |
DisclosureSEC source: 0001610717-26-000015 · form4.xml · nonDerivative · entry 2 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,134 F1 · shares: Represents shares underlying non-qualified stock options set to expire imminently on January 27, 2026. F2 · price: This transaction was executed in multiple trades at prices ranging from $14.85 to $15.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 23:01 UTC | Omada Health, Inc. OMDA · Entity 2364 | Exercise / conversionCommon Stock | 230,479 | $2.55 | $587,721.45 |
DisclosureSEC source: 0001610717-26-000015 · form4.xml · nonDerivative · entry 1 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 357,123 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 21:14 UTC | Omada Health, Inc. OMDA · Entity 2364 | SaleCommon Stock | 9,266 | $15.37 | $142,378.58 |
DisclosureSEC source: 0001610717-25-000416 · form4.xml · nonDerivative · entry 1 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 126,644 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by Sean P. Duffy on August 15, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.24 to $15.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 23:17 UTC | Omada Health, Inc. OMDA · Entity 2364 | Tax withholdingCommon Stock | 4,413 | $17.49 | $77,183.37 |
DisclosureSEC source: 0001610717-25-000414 · form4.xml · nonDerivative · entry 1 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,910 Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 21:05 UTC | Omada Health, Inc. OMDA · Entity 2364 | Tax withholdingCommon Stock | 4,413 | $24.28 | $107,147.64 |
DisclosureSEC source: 0001610717-25-000328 · form4.xml · nonDerivative · entry 1 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,323 Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 20:10 UTC | Omada Health, Inc. OMDA · Entity 2364 | GrantCommon Stock | 144,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-25-000175 · form4.xml · nonDerivative · entry 1 Duffy Sean P. · CIK 0002069522 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,736 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/16th of the RSUs vest on each quarterly anniversary measured from June 5, 2025 (the "Vesting Commencement Date"), such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.